Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. - Wikidata - wikimedia - TriplyDB

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

http://www.wikidata.org/entity/Q36691991

about

Multiple Sites Ultrasonography of Peripheral Nerves in Differentiating Charcot-Marie-Tooth Type 1A from Chronic Inflammatory Demyelinating Polyradiculoneuropathy.Neurofascin-155 as a putative antigen in combined central and peripheral demyelination Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Severe refractory CIDP: a case series of 10 patients treated with bortezomib.Novel Therapeutic Avenues for Chronic Inflammatory Demyelinating Polyneuropathy: The Difficulties of Disease Diversity.Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.Novel pathomechanisms in inflammatory neuropathies.Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP.Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.A New Classification System for IgG4 Autoantibodies.Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies Homozygous mutation in the Neurofascin gene affecting the glial isoform of Neurofascin causes severe neurodevelopment disorder with hypotonia, amimia and areflexia Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis

P2860

Q29994832-D945D4C9-CF3C-4ABC-81A2-E5A3249763F2 Q36981065-89CEDB8C-71D7-46F6-B2BF-8AA1F1F5D715 Q39434973-D9EBD7FA-7350-47DE-894A-BAAFF7602984 Q40081746-112CB915-E43B-4FAB-A8F2-BF72F46D9335 Q41002811-BF430F5A-DEBC-40E5-B4E2-DFCAC0D34851 Q42290388-B21779F2-D5DA-4489-B58F-1E4F9D75FF77 Q43533051-DA7C28E8-7E9E-4896-A381-20406AF05BFF Q46866734-5DC2722A-21D3-4889-9EB8-39FCC9D8D914 Q47126672-6150C26E-FC4F-414C-BB51-8D418259CCC2 Q47221782-FAAE7C23-8980-46C6-9918-3623633DBE3E Q47327481-0CD42CD8-EFD8-42A8-AEFB-6ED7E8D6D038 Q47610103-DC587DEA-8927-42B7-9D52-6D3822E89EAF Q47611455-3938288C-8070-454C-8BAA-E71D89E662A0 Q47978955-C100B368-FC64-46EA-852C-B7A6B848FEFC Q48110568-086EFD12-E108-4877-BA98-BCDF0080DC36 Q48172357-C534BA9C-C14D-4FF8-AF85-0A9694F1FC5B Q48301410-1E4098A1-F5C3-4BF2-89FE-C16933648694 Q50327901-51C32489-553D-4DD3-B591-DEC89E2B15EB Q52806003-9FD0B1DE-2625-4468-8CFA-01009F6EEDFC Q53174125-831DEE8A-C7DB-4E7F-8FFB-BA6C90EA3392 Q55021064-FFCAFEF5-9BAE-4ED8-836A-87AC9CD87636 Q57300562-E6B6EC1A-0737-40C4-839C-EE1B78B73622 Q57484322-D189D9ED-F291-4464-AEA1-B9E2AD3804FB Q58576008-C926E3A1-3FCD-4EC7-9C8E-3B6897CBBF56 Q58702983-9A608916-D6C5-4C3A-9811-69CB3C4AB7CF

P2860

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

http://www.wikidata.org/entity/Q36691991

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@ast

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@en

type

label

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@ast

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@en

prefLabel

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@ast

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@en

P1433

Q36691991-EC1AD0DE-54F0-4498-BD42-3CE2ACF15F09

P1476

Q36691991-24E1CDB6-F545-4252-AE20-8FE2D1A9FFA1

P2093

Q36691991-3095A1E5-B09E-4231-A037-399A263B3724

Q36691991-3107B5CE-6822-427E-A6E7-848852F916D7

Q36691991-32934763-D5F7-44E3-A104-00BE7A075452

Q36691991-4B038835-F8E1-4A35-B275-1C9E66243A0D

Q36691991-7B711D73-E1C4-49C2-A45F-5A98640D0FA7

Q36691991-91FFF51D-CF79-4569-A96B-08E5BBFEF031

Q36691991-92DB78B0-0687-4B6C-8CB8-A725FDEBF3AD

Q36691991-97AA8A3C-4F76-48E3-868C-2B893960B663

Q36691991-CD958EB7-7164-427D-A54D-7A8E419346F6

Q36691991-FA477209-8A17-4BC2-8703-F394DE5352DB

P2860

Q36691991-05CC0D7C-F4AF-42DA-B7D3-F224F389E162

Q36691991-0B1C818F-E4B5-4956-87B1-BC5AE97512C5

Q36691991-0CA0FE08-8BD0-41D3-A12F-95B44FB1917E

Q36691991-13A22B67-8A10-42DD-BEDC-D4D90F40238D

Q36691991-1FB2343D-9ECE-4AA4-A33C-41DDA7CB3764

Q36691991-28CA988D-C155-432B-ADE6-B9F1FB7B95C6

Q36691991-2EDE6FCC-0A90-4F3D-90FE-97917AECAB7F

Q36691991-3E60807D-D0DF-465D-936E-F800EA002438

Q36691991-4A63E524-6679-4AB1-9D87-25A5D51D1C4D

Q36691991-6AEF3C3F-A5A4-43EE-8AF0-5034AB444824

P304

Q36691991-0DAFA8C3-C796-460B-8A85-527D00D4829D

P31

Q36691991-334404D2-CDF2-47E3-A23D-25A84C553C2C

P356

Q36691991-FE484A70-E726-4249-A862-36EA22562D0F

P407

Q36691991-503530CC-C25C-49D6-83F5-DBE7C1CF9CEC

P433

Q36691991-E25459BA-EE33-4221-B21D-E9747574C786

P478

Q36691991-0706AFBD-98F5-45A8-A6BF-D515ACD2FCC8

P50

Q36691991-A7BC8307-44AE-44BF-90B0-55C6D0C1DCC7

P577

Q36691991-AEA79348-E242-4D8B-A18B-3B881A48317D

P698

Q36691991-555A01E8-B16E-4BC0-8AB8-233FF59CBF49

P932

Q36691991-BBFB090B-28D5-4A5E-8539-4044CEB1F1E7

P356

WNL.0000000000002418

P1433

P1476

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.

@en

P2093

Anna Hiu Yi Wong

http://www.w3.org/2001/XMLSchema#string

Constance Manso

http://www.w3.org/2001/XMLSchema#string

Hiroo Ichikawa

http://www.w3.org/2001/XMLSchema#string

Jérôme J Devaux

http://www.w3.org/2001/XMLSchema#string

Kenji Sekiguchi

http://www.w3.org/2001/XMLSchema#string

Maya Belghazi

http://www.w3.org/2001/XMLSchema#string

Norito Kokubun

http://www.w3.org/2001/XMLSchema#string

Takayuki Inoue

http://www.w3.org/2001/XMLSchema#string

Yuki Fukami

http://www.w3.org/2001/XMLSchema#string

Yumako Miura

http://www.w3.org/2001/XMLSchema#string

P2860

Guillain–Barré and Miller Fisher syndromes—new diagnostic classification

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction

In vivo deletion of immunoglobulin domains 5 and 6 in neurofascin (Nfasc) reveals domain-specific requirements in myelinated axons

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin.

Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement deposition.

Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia

Neurofascin as a target for autoantibodies in peripheral neuropathies.

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

P304

800-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000002418

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26843559

http://www.w3.org/2001/XMLSchema#string

P932

4793783

http://www.w3.org/2001/XMLSchema#string